Puren Pharmaceutical | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

13,543 results for “Puren Pharmaceutical”

FDA Clears Pharmosa Biopharm's Inhaled Drug L608 for Phase 2 Trial

HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)

German Court Grants Sales Ban for Generic Fampridine Products Following Patent Victory for Merz

EU Officials Tout Pending Pharmaceutical Reforms

Pharmaceutical R&D Highlights: Key Clinical Updates from November 2024

Lilly Expands Obesity Treatment Pipeline Through KeyBioscience Collaboration

FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa

SPIMA Therapeutics Launches with Focus on Peptide-Based Immunotherapies for Unmet Needs

RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development

Merck & Co. to Acquire WuXi Biologics' Vaccine Facility in Ireland for $500 Million

Page 1 of 893